A method for quantitative assessment of renal function using dynamic contrast-enhanced computed tomography: Evaluation of drug-induced nephrotoxicity in rats

Medical Physics

Volumn 35, Issue 12, 2008, Pages 5768-5776

  Murase, Kenya ^a   Tachibana, Atsushi ^a   Kusakabe, Yoshinori ^a   Matsuura, Risa ^a   Miyazaki, Shohei ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal experiment; Cisplatin induced nephrotoxicity; Dynamic contrast enhanced CT; Renal function

Indexed keywords

CONTROLLED DRUG DELIVERY; FUNCTION EVALUATION; LEAST SQUARES APPROXIMATIONS; RATE CONSTANTS; RATS;

ANIMAL EXPERIMENTS; ARTERIAL INPUT FUNCTION; DYNAMIC CONTRAST ENHANCED; LINEAR LEAST-SQUARES METHOD; NEPHROTOXICITY; PARTIAL VOLUME EFFECT; QUANTITATIVE ASSESSMENTS; RENAL FUNCTIONS;

COMPUTERIZED TOMOGRAPHY;

CISPLATIN; CREATINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE CLEARANCE; DYNAMIC CONTRAST ENHANCED COMPUTED TOMOGRAPHY; IMAGING SYSTEM; KIDNEY FUNCTION TEST; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

EID: 56749186065     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3020595     Document Type: Article

References (28)

1. A. Cenic, D. G. Nabavi, R. A. Craen, A. W. Gelb, and T. Y. Lee, " A CT method to measure hemodynamics in brain tumors: Validation and application of cerebral blood flow maps.," AJNR Am. J. Neuroradiol. 21, 462-470 (2001).
2. Y. Ohno, H. Hatabu, K. Murase, T. Higashino, H. Kawamitsu, H. Watanabe, D. Takenaka, M. Fujii, and K. Sugimura, " Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects.," J. Magn. Reson Imaging 20, 353-365 (2004).
3. Y. Sugawara, K. Murase, K. Kikuchi, K. Sakayama, T. Miyazaki, M. Kajihara, H. Miki, and T. Mochizuki, " Measurement of tumor blood flow using dynamic contrast-enhanced magnetic resonance imaging and deconvolution analysis: A preliminary study in musculoskeletal tumors.," J. Comput. Assist. Tomogr. 30, 983-990 (2006).
4. R. Materne, B. E. Van Beers, A. M. Smith, I. Leconte, J. Jamart, J.-P. Dehoux, A. Keyeux, and Y. Horsmans, " Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartment model.," Clin. Sci. 99, 517-525 (2000).
5. L. Bogin, R. Margalit, J. Mispelter, and H. Degani, " Parametric imaging of tumor perfusion using flow- and permeability-limited tracers.," J. Magn. Reson Imaging 16, 289-299 (2002).
6. K. M. Donahue, R. M. Weisskoff, and D. Burstein, " Water diffusion and exchange as they influence contrast enhancement.," J. Magn. Reson Imaging 7, 102-110 (1997).
7. R. M. Judd, S. B. Reeder, and K. May-Newman, " Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents.," Magn. Reson. Med. 41, 334-342 (1999).
8. H. I. Kornblum, D. M. Araujo, A. J. Annala, K. J. Tatsukawa, M. E. Phelps, and S. R. Cherry, " In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET).," Nat. Biotechnol. 18, 655-660 (2000).
9. G. Krishnamurthi, K. M. Stantz, R. Steinmetz, V. H. Gattone, M. Cao, G. D. Hutchins, and Y. Liang, " Functional imaging in small animals using x-ray computed tomography-Study of physiologic measurement reproducibility., " IEEE Trans. Med. Imaging 24, 832-843 (2005).
10. Y. Tsushima, " Functional CT of the kidney.," Eur. J. Radiol. 30, 191-197 (1999).
11. R. F. Borch and M. E. Pleasants, " Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.," Proc. Natl. Acad. Sci. U.S.A. 76, 6611-6614 (1979).
12. R. Safirstein, P. Miller, S. Dikman, N. Lyman, and C. Shapiro, " Cisplatin nephrotoxicity in rats: Defect in papillary hypertonicity.," Am. J. Physiol. 241, F175-F185 (1981).
13. J. A. Winston and R. Safirstein, " Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat.," Am. J. Physiol. 249, F490-F496 (1985).
14. K. Murase, " Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging.," Magn. Reson. Med. 51, 858-862 (2004).
15. M. Yamada, " Assessment of Tc 99m -DMSA renoscintigraphy and uptake compared with creatinine clearance in rats with drug-induced nephrotoxicity. II. Cisplatin-induced nephrotoxicity.," Jpn. J. Nucl. Med. 28, 347-354 (1991) (in Japanese).
16. A. Cenic, D. G. Nabavi, R. A. Craen, A. W. Gelb, and T.-Y. Lee, " Dynamic CT measurement of cerebral blood flow: A validation study.," AJNR Am. J. Neuroradiol. 20, 63-73 (1999).
17. J. S. Cameron, Renal Function Testing (Oxford University Press, Oxford, 1992), pp. 24-71.
18. A. S. Levey, M. P. Madaio, and R. D. Perrone, The Kidney (WB Saunders, Philadelphia, 1991), pp. 919-963.
19. L. M. Tsai, C. C. Lin, W. C. Huang, and T. K. Young, " Attenuation of natriuretic response to saline loading in AV3V lesioned rats.," Clin. J. Physiol. 29, 31-41 (1986).
20. F. Saez, M. T. Castells, A. Zuasti, F. Salazar, V. Reverte, A. Loria, and F. J. Salazar, " Sex differences in the renal changes elicited by angiotensin II blockade during the nephrogenic period.," Hypertension 49, 1429-1435 (2007).
21. T. C. Pearson and G. Wetherley-Mein, " Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia.," Lancet 2, 1219-1222 (1978).
22. K. A. Miles and M. R. Griffiths, " Perfusion CT: A worthwhile enhancement?," Br. J. Radiol. 76, 220-231 (2003).
23. C. S. Patlak, R. G. Blasberg, and J. D. Ferstenmacher, " Graphical evaluation of blood to brain barrier transfer contrasts from multiple time-uptake data.," J. Cereb. Blood Flow Metab. 3, 1-7 (1983).
24. N. Hackstein, J. Bauer, E. W. Hauck, M. Ludwig, H.-J. Kramer, and W. S. Rau, " Measuring single-kideny glomerular filtration rate on single-detector helical CT using a two-point Patlak plot technique in patients with increased interstitial space.," AJR, Am. J. Roentgenol. 181, 147-156 (2003).
25. L. Annet, L. Hermoye, F. Peeters, F. Jamar, J.-P. Dehoux, and B. E. Van Beers, " Glomerular filtration rate: Assessment with dynamic contrast-enhanced MRI and a cortical-compartment model in the rabbit kidney.," J. Magn. Reson Imaging 20, 843-849 (2004).
26. D. L. Buckley, A. E. Shurrab, C. M. Cheung, A. P. Jones, H. Mamtora, and P. A. Kaira, " Measurement of single kidney function using dynamic contrast-enhanced MRI: Comparison of two models in human subjects.," Magn. Reson. Med. 24, 1117-1123 (2006).
27. K. Kawakami, K. Murase, M. Kumashiro, A. Kawakami, N. Tanki, Y. Yamazaki, T. Tabuchi, M. Nagayama, and Y. Watanabe, " Automatic motion correction for quantification of myocardial perfusion with dynamic magnetic resonance imaging.," Magn. Reson. Med. Sci. 3, 105-117 (2004).
28. X. Yao, K. Panichpisal, N. Kurtzman, and K. Nugent, " Cisplatin nephrotoxicity: A review.," Am. J. Med. Sci. 334, 115-124 (2007).